Gene Logic will pay recently appointed CEO and president Charles Dimmler $425,000  in salary plus an incentive package worth as much as 40 percent of his salary.
 
The company also gave Dimmler an option to buy as much as 120,000 shares of the company’s common stock at $1.37 per share that will vest in four increments spread out over three years, as well as a total of 130,000 shares as bonuses if the company achieves milestones. 


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.